Point72 Hong Kong’s ResMed RMD Stock Holding History

Point72 Hong Kong’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-840	Closed	-$176K	–	2355
2022 Q2	$176K	Buy	+840	New	+$179K	0.01%	1014
2021 Q2	–	Sell	-1,533	Closed	-$322K	–	2290
2021 Q1	$297K	Sell	1,533 -9	-0.6%	-$1.8K	0.01%	967
2020 Q4	$328K	Sell	1,542 -2,404	-61%	-$479K	0.01%	820
2020 Q3	$676K	Buy	+3,946	New	+$729K	0.07%	250
2019 Q4	–	Sell	-3,307	Closed	-$447K	–	1416
2019 Q3	$447K	Buy	+3,307	New	+$433K	0.13%	112
2019 Q2	–	Sell	-3,122	Closed	-$325K	–	1363
2019 Q1	$325K	Buy	3,122 +1,802	+137%	+$186K	0.13%	84
2018 Q4	$150K	Buy	+1,320	New	+$141K	0.07%	126
2018 Q1	–	Sell	-107	Closed	-$9K	–	1109
2017 Q4	$9K	Buy	+107	New	+$8.84K	0.01%	510
2016 Q2	–	Sell	-700	Closed	-$40K	–	645
2016 Q1	$40K	Buy	+700	New	+$39.6K	0.08%	191

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Point72 Hong Kong's RMD Position: Q3 2022 in Review

Point72 Hong Kong sold out of ResMed (RMD) in Q3 2022, closing a stake of 840 shares — an estimated $176K sold.

Point72 Hong Kong first reported a position in RMD in Q1 2016 and held it in 9 quarters. The position peaked at $676K in Q3 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Point72 Hong Kong reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 840 ResMed shares in Q3 2022, an estimated $176K.
Point72 Hong Kong first reported a position in ResMed in Q1 2016 and held it in 9 quarters.
Point72 Hong Kong's ResMed position peaked at $676K in Q3 2020.
667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.